Cargando…
Secondary findings in a large Pakistani cohort tested with whole genome sequencing
Studies on genomic secondary findings (SFs) are diverse in participants’ characteristics, sequencing methods, and versions of the ACMG SF list. Based on whole genome sequencing and the version 3.1 of the ACMG SF list, we studied SFs in 863 individuals from five different regions in Pakistan. We iden...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838216/ https://www.ncbi.nlm.nih.gov/pubmed/36635046 http://dx.doi.org/10.26508/lsa.202201673 |
_version_ | 1784869233607311360 |
---|---|
author | Skrahin, Aliaksandr Cheema, Huma Arshad Hussain, Maqbool Rana, Nuzhat Noureen Rehman, Khalil Ur Kumar, Raman Oprea, Gabriela Ameziane, Najim Rolfs, Arndt Skrahina, Volha |
author_facet | Skrahin, Aliaksandr Cheema, Huma Arshad Hussain, Maqbool Rana, Nuzhat Noureen Rehman, Khalil Ur Kumar, Raman Oprea, Gabriela Ameziane, Najim Rolfs, Arndt Skrahina, Volha |
author_sort | Skrahin, Aliaksandr |
collection | PubMed |
description | Studies on genomic secondary findings (SFs) are diverse in participants’ characteristics, sequencing methods, and versions of the ACMG SF list. Based on whole genome sequencing and the version 3.1 of the ACMG SF list, we studied SFs in 863 individuals from five different regions in Pakistan. We identified 24 ACMG SFs in 23 (2.7%) of 863 individuals: 18 of 24 were related to cardiovascular disease and four to cancer syndromes. In addition to ACMG SFs, we identified 16 (1.9%) participants with pathogenic and likely pathogenic variants in genes that were not related to the participants’ clinical conditions but with clear medical actionability (non-ACMG SFs): 4 of 16 were related to eye diseases, two to metabolic disorders, and two to urinary system disorders. By testing a large Pakistani cohort with whole genome sequencing, we concluded that in countries such as Pakistan, the ACMG SF list could be expanded, and our non-ACMG SF list is one example. |
format | Online Article Text |
id | pubmed-9838216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Life Science Alliance LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-98382162023-01-14 Secondary findings in a large Pakistani cohort tested with whole genome sequencing Skrahin, Aliaksandr Cheema, Huma Arshad Hussain, Maqbool Rana, Nuzhat Noureen Rehman, Khalil Ur Kumar, Raman Oprea, Gabriela Ameziane, Najim Rolfs, Arndt Skrahina, Volha Life Sci Alliance Research Articles Studies on genomic secondary findings (SFs) are diverse in participants’ characteristics, sequencing methods, and versions of the ACMG SF list. Based on whole genome sequencing and the version 3.1 of the ACMG SF list, we studied SFs in 863 individuals from five different regions in Pakistan. We identified 24 ACMG SFs in 23 (2.7%) of 863 individuals: 18 of 24 were related to cardiovascular disease and four to cancer syndromes. In addition to ACMG SFs, we identified 16 (1.9%) participants with pathogenic and likely pathogenic variants in genes that were not related to the participants’ clinical conditions but with clear medical actionability (non-ACMG SFs): 4 of 16 were related to eye diseases, two to metabolic disorders, and two to urinary system disorders. By testing a large Pakistani cohort with whole genome sequencing, we concluded that in countries such as Pakistan, the ACMG SF list could be expanded, and our non-ACMG SF list is one example. Life Science Alliance LLC 2023-01-12 /pmc/articles/PMC9838216/ /pubmed/36635046 http://dx.doi.org/10.26508/lsa.202201673 Text en © 2023 Skrahin et al. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Articles Skrahin, Aliaksandr Cheema, Huma Arshad Hussain, Maqbool Rana, Nuzhat Noureen Rehman, Khalil Ur Kumar, Raman Oprea, Gabriela Ameziane, Najim Rolfs, Arndt Skrahina, Volha Secondary findings in a large Pakistani cohort tested with whole genome sequencing |
title | Secondary findings in a large Pakistani cohort tested with whole genome sequencing |
title_full | Secondary findings in a large Pakistani cohort tested with whole genome sequencing |
title_fullStr | Secondary findings in a large Pakistani cohort tested with whole genome sequencing |
title_full_unstemmed | Secondary findings in a large Pakistani cohort tested with whole genome sequencing |
title_short | Secondary findings in a large Pakistani cohort tested with whole genome sequencing |
title_sort | secondary findings in a large pakistani cohort tested with whole genome sequencing |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838216/ https://www.ncbi.nlm.nih.gov/pubmed/36635046 http://dx.doi.org/10.26508/lsa.202201673 |
work_keys_str_mv | AT skrahinaliaksandr secondaryfindingsinalargepakistanicohorttestedwithwholegenomesequencing AT cheemahumaarshad secondaryfindingsinalargepakistanicohorttestedwithwholegenomesequencing AT hussainmaqbool secondaryfindingsinalargepakistanicohorttestedwithwholegenomesequencing AT rananuzhatnoureen secondaryfindingsinalargepakistanicohorttestedwithwholegenomesequencing AT rehmankhalilur secondaryfindingsinalargepakistanicohorttestedwithwholegenomesequencing AT kumarraman secondaryfindingsinalargepakistanicohorttestedwithwholegenomesequencing AT opreagabriela secondaryfindingsinalargepakistanicohorttestedwithwholegenomesequencing AT amezianenajim secondaryfindingsinalargepakistanicohorttestedwithwholegenomesequencing AT rolfsarndt secondaryfindingsinalargepakistanicohorttestedwithwholegenomesequencing AT skrahinavolha secondaryfindingsinalargepakistanicohorttestedwithwholegenomesequencing |